(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DASH PHARMACEUTICALS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DASH PHARMACEUTICALS

ST13

US500000086983458

Class

5

Filing

86983458

Registration

5381367

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

57

Latest update

02/19/2024

Trademark type

Word

Nice classes

5

Filing date

09/20/2014

Registration date

01/16/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/07/2023

Last transaction

02/19/2024

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

05/31/2017

First use in commerce

05/31/2017

Drawing code

4

Owner type

16

Owner location

Parsippany, NJ

Examiner

RIEPEL, CHRISTINA

Law office

N60

Current location

TMO LAW OFFICE 124

Holders and representatives

Holders

NATCO PHARMA USA LLC
DASH PHARMACEUTICALS LLC
Fidelity Pharmaceuticals LLC

Representatives

Michael A. Marrero UB Greensfelder LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Antihistamines; medical compounds for use as antihistaminesanti-cholinerics* and* antipruriticsserotonin antagonists; anti-inflammatories; pharmaceuticals in the nature of anti-inflammatory analgesic agents with gastro-protective properties; anti-ulcer preparations

Publications

History of USPTO decisions and trademark events.

57 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/19/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/19/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/19/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/19/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

02/19/2024

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

09/07/2023

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

09/07/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/07/2023

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

05/17/2023

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

04/19/2023

E815

TEAS SECTION 8 & 15 RECEIVED

03/07/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/16/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

01/16/2018

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/14/2017

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/13/2017

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/13/2017

SUPC

STATEMENT OF USE PROCESSING COMPLETE

12/12/2017

DPCC

DIVISIONAL PROCESSING COMPLETE

12/12/2017

EX1G

SOU EXTENSION 1 GRANTED

12/12/2017

IROA

RESPONSE TO ITU OFFICE ACTION ENTERED

12/07/2017

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

12/07/2017

INCD

ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST

12/06/2017

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/27/2017

IUAF

USE AMENDMENT FILED

11/20/2017

DRRR

DIVISIONAL REQUEST RECEIVED

11/20/2017

EXT1

SOU EXTENSION 1 FILED

11/20/2017

EISU

TEAS STATEMENT OF USE RECEIVED

11/20/2017

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

11/20/2017

EEXT

SOU TEAS EXTENSION RECEIVED

11/20/2017

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/27/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/02/2017

PUBO

PUBLISHED FOR OPPOSITION

05/02/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/12/2017

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/27/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/11/2017

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

02/23/2017

ALIE

ASSIGNED TO LIE

02/20/2017

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

08/16/2016

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

02/16/2016

NREV

NOTICE OF REVIVAL - E-MAILED

08/13/2015

GRML

CORRESPONDENCE E-MAILED

08/13/2015

CNSL

SUSPENSION LETTER WRITTEN

08/13/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/13/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/13/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/13/2015

PETG

PETITION TO REVIVE-GRANTED

08/13/2015

PROA

TEAS PETITION TO REVIVE RECEIVED

08/13/2015

MAB2

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

08/06/2015

ABN2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

08/06/2015

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/08/2015

GNRT

NON-FINAL ACTION E-MAILED

01/08/2015

CNRT

NON-FINAL ACTION WRITTEN

01/08/2015

DOCK

ASSIGNED TO EXAMINER

01/06/2015

TAEA

TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED

10/02/2014

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

10/02/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/29/2014

NWAP

NEW APPLICATION ENTERED

09/24/2014

Continuous trademark protection

Get notified about every new filing that threatens DASH PHARMACEUTICALS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.